Skip to main content
SpringerLink
Log in

Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: Should Graves’ disease be considered a collagen disorder?

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The identity and subcellular localization of the principal extraocular muscle (EOM) antigens and prevalences of the corresponding serum autoantibodies in thyroid-associated ophthalmopathy (TAO) need to be clarified. We have used porcine eye muscle tissue, which expresses all autoantigens identified in human tissue, as substrate in an indirect immunofluorescence assay. Several different patterns of antibody binding to EOM tissue antigens were observed with sera from patients with TAO namely, membrane, cytoplasmic, interstitial (endomysial) and nuclear. Overall, sera from 75% of patients with TAO contained one or more antibodies reactive with EOM, compared to 32% of patients with Graves’ hyperthyroidism, 38% with Hashimoto’s thyroiditis, and 16% of normals. All sera which reacted with EOM membrane or cytoplasmic antigens also reacted with the same antigen(s) in other skeletal muscle, but not in the other tissues tested. Sera from 31% of patients with TAO, but only 7% of those with Hashimoto’s thyroiditis, and no patient with Graves’ hyperthyroidism without evident ophthalmopathy, contained antinuclear antibodies (ANA). The most common nuclear fluorescence pattern was the finely speckled type typically associated with anti-Sm or anti-RNP antibodies. Significant positive correlations in patients with TAO were found between (i) EOM dysfunction and ANA (ii) eye disease of <1 yr duration and EOM membrane-reactive antibodies and (iii) eye disease of <1 yr duration and interstitial (endomysial) tissue-reactive antibodies. Although patients with Graves’ disease do not usually exhibit other signs or immunologic features of a generalized collagen disorder, the finding of high prevalences of ANA and anti-striated muscle antibodies and, less often, anti-connective tissue antibodies in patients with ophthalmopathy, is consistent with it being a collagen-like disorder of the striated muscle, connective tissue and the thyroid. The reason why the inflammatory process is mainly limited to these tissues is unclear although cross reaction of ANA with tissue specific proteins or increased expression of muscle and connective tissue antigens in the orbit and skin, are possibilities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burch H.B., Wartofsky L. Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr. Rev. 14: 747, 1993.

    PubMed  CAS  Google Scholar 

  2. Kiljanskli J.I., Nebes V., Wall J.R. The ocular muscle cell is a target of the immune system in endocrine ophthalmopathy. Int. Arch. Allergy Immunol. 106: 204, 1995.

    Article  Google Scholar 

  3. Toccafondi R., Rotella C. M., Zonferati R., Tanini A. Humoral factors in Graves’ ophthalmopathy. In: Pinchera A., Ingbar S.H., McKenzie J.M., Fenzi G.F. (Eds), Thyroid Autoimmunity. Plenum Press, New York, 1987, p. 99.

    Chapter  Google Scholar 

  4. Bahn R.S., Smith T.J., Gorman C.A. The central role of the fibroblast in the pathogenesis of extrathyroidal manifestations of Graves’ disease. Acta Endocrinol. (Copenh.) 121: 75, 1989.

    Google Scholar 

  5. Bahn R.S., Gorman C.A., Johnson C.M., Smith T.J. Presence of antibodies in the sera of patients with Graves’ disease recognizing a 23 kilodalton fibroblast protein. J. Clin. Endocrinol. Metab. 69: 622, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Bahn R.S., Heufelder A.E. Orbital connective tissue in endocrine ophthalmopathy. In: Kahaly G. (Ed.), Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol., Karger, Basel, 1993, p. 46.

    Google Scholar 

  7. Heufelder A.E., Bahn R. S. Elevated expression in situ of selectin and immunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves’ ophthalmopathy. Clin. Exp. Immunol. 91: 381, 1993.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. Wall J.R., Strakosch C.R., Fang S.L., Ingbar S.H., Braverman L.E. Thyroid binding antibodies and other immunological abnormalities in patients with Graves’ ophthalmopathy: effect of treatment with cyclophosphamide. Clin. Endocrinol. 10: 79, 1979.

    Article  CAS  Google Scholar 

  9. Wall J.R., Trewin A., Fang S. L., Ingbar S. H., Braverman L.E. Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves’ disease. J. Endocrinol. Invest. 1: 253, 1978.

    Article  PubMed  CAS  Google Scholar 

  10. McDermott M.T., West S.G., Emlen J.W., Kidd G.S. Antideoxyribonucleic acid antibodies in Graves’ disease. J. Clin. Endocrinol. Metab. 71: 509, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Bartalena L., Martino E., Grasso L. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 14: 33, 1992.

    PubMed  Google Scholar 

  12. Kapusta M., Salvi M., Triller H., Gardini E., Bernard N., Wall J.R. Eye muscle membrane reactive antibodies are not detected in serum or immunoglobulin fraction of patients with thyroid-associated ophthalmopathy using ELISA and crude membranes. Autoimmunity 7: 33, 1990.

    Article  PubMed  CAS  Google Scholar 

  13. Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J.R. Demonstration of circulating antibody against a soluble eye muscle antigen in Graves’ ophthalmopathy. Lancet ii: 1353, 1982.

    Article  Google Scholar 

  14. Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves’ ophthalmopathy. Lancet ii: 374, 1984.

    Article  Google Scholar 

  15. Miller A., Sikorska H., Salvi M., Wall J.R. Evaluation of an enzyme-linked immunosorbent assay for the measurement of antibodies against eye muscle membrane antigens in Graves’ ophthalmopathy. Acta Endocrinol. (Copenh.) 113: 514, 1986.

    CAS  Google Scholar 

  16. Salvi M., Miller A., Wall J.R. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy. FEBS Lett. 232: 135, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Kendler D.L., Rootman J., Huber G. K., Davies T.F. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves’ thyroid and ophthalmic diseases. Clin. Endocrinol. (Oxf.) 35: 539, 1991.

    Article  CAS  Google Scholar 

  18. Hiromatsu Y., Sato M., Tanaka K., Shoji S., Nonaka K., Chinami M., Fukazawa H. Significance of anti-eye muscle antibody in patients with thyroid associated ophthalmopathy by quantitative Western blot. Autoimmunity 14: 18, 1993.

    Article  Google Scholar 

  19. Wall J.R., Scalise D., Hayes M., Stolarski C., Nebes V., Kiljansk J., Salvi M., Sato Native gel electrophoresis and isoelectric focusing of a 64kilodalton eye muscle protein shows that it is an important target for serum autoantibodies in patients with thyroid-associated ophthalmopathy and not expressed in other skeletal muscle. J. Clin. Endocrinol. Metab. 80: 1226, 1995.

    PubMed  CAS  Google Scholar 

  20. Faryna M., Nauman J., Gardas J. Measurements of autoantibodies against human eye muscle membranes in Graves’ ophthalmopathy. Br. Med. J. 59: 104, 1985.

    Google Scholar 

  21. Mengistu M., Laryea E., Miller A., Wall J. Clinical significance of a new autoantibody against a human muscle soluble antigen, detected by immunofluorescence. Clin. Exp. Immunol. 65: 19, 1986.

    PubMed Central  PubMed  CAS  Google Scholar 

  22. Fischer S., Heberling H.J., Klugmannk T., Lohmann D., Eichler C.H. Antibodies against various retroorbital eye muscle antigens and sonographic findings in patients with autoimmune orbitopathy. In: Proc. Thyroid Symp., 150th Anniversary of Basedow’s Disease (abstract), 1990.

  23. Kandror V., Birjukova M., Kryukova I., Mkrtumova N., Konnova E. Some immunological correlations between thyroid pathology and ophthalmopathy. Exp. Clin. Endocrinol. 97: 212, 1991.

    Article  PubMed  CAS  Google Scholar 

  24. Triller H., Chungh F., Rodien P., Boucher A., Liberman A., Bernard N.F., Ludgate M., Wall J. Antibodies reactive with an intracellular fragment of a recombinant 64 kDa thyroid and eye muscle protein are associated with thyroid autoimmunity and ophthalmopathy. J. Endocrinol. Invest. 16: 863, 1994.

    Google Scholar 

  25. Hiromatsu Y., Fukazawa H., Guinard F., Salvi M., How J., Wall J.R. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid-associated ophthalmopathy. J. Clin. Endocrinol. Metab. 67: 565, 1988.

    Article  PubMed  CAS  Google Scholar 

  26. Hiromatsu Y., Fukazawa H., How J., Wall J.R. Antibody dependent cell mediated cytotoxicity against human eye muscle cells and orbital fibroblasts in Graves’ ophthalmopathy — roles of Class II MHC antigen expression and interferon action on effector and target cells. Clin. Exp. Immunol. 70: 593, 1987.

    PubMed Central  PubMed  CAS  Google Scholar 

  27. Hiromatsu Y., Cadarso L., Salvi M., Wall J.R. Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy. Autoimmunity 5: 205, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Wall J. Nature and significance of eye muscle antigens in endocrine ophthalmopathy. In: Kahaly G. (Ed.), Endocrine Ophthalmopathy. Molecular, Immunological and Clinical Aspects. Dev. Ophthalmol., Karger, Basel, 1993 p. 77.

    Google Scholar 

  29. Teboul N., Trillel H., Chun F., Bernard N., Zhan G., Wall J.R. Muscle and species reactivity of mouse monoclonal antibodies to human eye muscle membrane antigens. Clin. Immunol. Immunopathol. 59: 104, 1991.

    Article  PubMed  CAS  Google Scholar 

  30. Committees of Regional Thyroid Associations Classification of eye changes of Graves’ disease. Thyroid 2: 235, 1992.

    Google Scholar 

  31. Nakamura R. Autoantibodies to nuclear antigens (ANA). Advances in laboratory tests and significance in rheumatic disease. Am. Soc. Clin. Pathologists Press, Chicago, 1985, p 3.

    Google Scholar 

  32. Laemmlik U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227: 680, 1970.

    Article  Google Scholar 

  33. Triller H., Chung F., Tsao M., Bouche A., Rodien P., Liberman A., Bernard N., Wall J.R. Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes. J. Endocrinol. Invest. 17: 105, 1994.

    PubMed  Google Scholar 

  34. Konstadoulaki M.M., Kroubouzo G., Tosca A., Piperingos G., Marafelia P., Konstadoulakis M., Varelzidis A., Koutras D.A. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology 5: 1, 1993.

    Google Scholar 

  35. Gordon T., Isenberg D. Organ specific and multisystem autoimmune disease: Part of a spectrum which may coexist in the same patient. Clin. Rheumatol. 9: 401, 1990.

    Article  PubMed  CAS  Google Scholar 

  36. McCombe P.A., Chalk J.B., Pender M.P. Familial occurrence of multiple sclerosis with thyroid disorder and systemic lupus erythematosus. J. Neurol. Sci. 97: 163, 1990.

    Article  PubMed  CAS  Google Scholar 

  37. Loviselli A., Velluzzi, F., Pala R., Marcello A., Nurchi P., Mathieu A., Dagenais P., Urowitz M.B., Gladman D.D., Norman C.S. A family study of the antiphospholipid syndrome associated with other autoimmune diseases. J. Rheumatol. 19: 1393, 1992.

    Google Scholar 

  38. Loviselli A., Velluzi F., Pala R., Marcello E., Nurchis P., Mathieu A., Bartalena L., Martino E., Grasso L. Circulating antibodies to DNA-related antigens in patients with autoimmune thyroid disorders. Autoimmunity 14: 33, 1992.

    Article  PubMed  CAS  Google Scholar 

  39. Tajirik J., Higashi K., Morita M., Ohishi S., Umeda T., Sato T. Elevation of antiDNA antibody titer during thyrotoxic phase of silent thyroiditis. Arch. Intern. Med. 146: 1623, 1986.

    Article  Google Scholar 

  40. Katakura M., Yamada T., Aizawak T., Hiromatsu A K., Yakimura Y., Ishihara M., Takas N., Maruyamak K., Kanai M., Kobays I. Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves’ disease. J. Clin. Endocrinol. Metab. 64: 405, 1987.

    Article  PubMed  CAS  Google Scholar 

  41. Tachi J., Amino N., Iwatani Y., Mori M., Aozasa M., Tanizaw O., Miyai K. Increase in antideoxiribonucleic acid antibody titer in postpartum aggravation of autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 67: 1049, 1988.

    Article  PubMed  CAS  Google Scholar 

  42. Baethge B.A., Levine S.N., Wolf R.E. Antibodies to nuclear antigens in Graves’ disease. J. Clin. Endocrinol. Metab. 66: 485, 1988.

    Article  PubMed  CAS  Google Scholar 

  43. Moritah S., Arimak T., Matsuda M. Prevalence of nonthyroid specific antibodies in autoimmune thyroid diseases. J. Clin. Endocrinol. Metab. 80: 1203, 1995.

    Google Scholar 

  44. Arnaout M.A., Nasarallah N.S., el-Khateeb M.S. Prevalence of abnormal thyroid function tests in connective tissue disease. Scand. J. Rheumatol. 23: 128, 1994.

    Article  PubMed  CAS  Google Scholar 

  45. Salvih M., De Chiara F., Gardini E., Minelli R., Bianconi L., Alnovi A., Ricci R., Neri F., Tosi C., Roti E. Echocardiographic diagnosis of pretibial myxedema in patients with autoimmune thyroid disease. Acta Endocrinol. (Copenh.) 131: 113, 1994.

    Google Scholar 

  46. Dudgeon L. S., Urquhart A.L. Lymphorrhages in the muscle in exophthalmic goitre. Brain 49: 182, 1975.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Medical Research Center, Polish Academy of Science, Warsaw, Banacha 1a, Poland

    J. I. Kiljanski

  2. Department of Pathology, Allegheny General Hospital, Pittsburgh, USA

    K. Peele, I. Stachura & J. Pickeral

  3. Thyroid-Eye Disease Research Laboratory, Allegheny University of the Health Sciences, Pittsburgh, PA, USA

    C. Stolarski, J. S. Kennerdell & J. R. Wall

Authors
  1. J. I. Kiljanski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Peele
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Stachura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Pickeral
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Stolarski
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. S. Kennerdell
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. R. Wall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kiljanski, J.I., Peele, K., Stachura, I. et al. Antibodies against striated muscle, connective tissue and nuclear antigens in patients with thyroid-associated ophthalmopathy: Should Graves’ disease be considered a collagen disorder?. J Endocrinol Invest 20, 585–591 (1997). https://doi.org/10.1007/BF03346914

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346914

Key-words

Search

Navigation